title: [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
authors.affiliation: yoshi@imed3.med.osaka-u.ac.jp
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Oka
authors.forename: Akihiro
authors.initials: A
authors.lastname: Tsuboi
authors.forename: Haruo
authors.initials: H
authors.lastname: Sugiyama
mesh_terms: D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D019496:Cancer Vaccines; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D007111:Immunity, Cellular; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007134:Immunoglobulin Switch Region; D007167:Immunotherapy / Q000379:methods*; D016233:Immunotherapy, Active; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D025721:WT1 Proteins / Q000276:immunology
chemical_list: D000912:Antibodies, Neoplasm; D019496:Cancer Vaccines; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D025721:WT1 Proteins